MiRNA-based therapy for Cardiac Ischemic injury: MiRNA-331-3p decreases infarct size and remodelling and augments cardiac function via down regulation of its target gene, 1/March/2016, 16.30

Natural product-based therapy for Emphysema: Icariin, a flavanoid and PDE-5 inhibitor, inhibits inflammation and protects against Emphysema via up regulation of its target gene, 1/March/2016, 10.21 am
March 1, 2015
Anti-metastasis therapy: Sirtuin-2 suppresses the expression of PD-1 , a suppressor of activation of T-cells, via down regulation of its target gene, 1/March/2015, 17.04
March 1, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Citation: Boominathan, MiRNA-based therapy for Cardiac Ischemic injury: MiRNA-331-3p decreases infarct size and remodelling and augments cardiac function via down regulation of its target gene, 1/March/2016, 16.30, http://genomediscovery.org

 

Significance: This study suggests that MiRNA-331-3p, by decreasing the expression of its target gene, may enhance cardiac function. Thus,  pharmacological formulations encompassing “MiRNA-331-3p or its activators may be used to treat Cardiac Ischemic injury.

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Undisclosed information: How MiRNA-331-3p protects against Cardiac Ischemic injury.

Amount: $500*

Comments are closed.